Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Dyee Capital

Investor type Venture Capital
Founders Dezhen Zhu

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 27
Average round size
info
The average size of a deal this fund participated in
$50M
Portfolio companies 23
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.15
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Biopharma
  • Logistics
Summary

The main office of represented VC is situated in the Xiamen. The company was established in Asia in China.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Dyee Capital, startups are often financed by RMB Funds, Legend Capital, China Growth Capital. The meaningful sponsors for the fund in investment in the same round are Lilly Asia Ventures, Capital Today, Xiamen C&D Corporation. In the next rounds fund is usually obtained by Silicon Valley Bank, Qualcomm Ventures, Legend Capital.

Among the most popular portfolio startups of the fund, we may highlight FineEx, Hebaodan, Borns Robot. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are E-Commerce, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

This organization was formed by Dezhen Zhu.

The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2018. The fund is generally included in 2-6 deals every year. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Dyee Capital:
Typical Co-investors
Dyee Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Dyee Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Adolfsen Group -
Ajuntament de Barcelona -
Birmingham City Council Birmingham, England, United Kingdom
Bulldog Innovation Group LLC Connecticut, New Haven, United States
Cassidy Asset Management -
CH Investment Partners Dallas, Texas, United States
Computime Equity Ventures Missouri, Saint Louis, United States
Encourage Technologies Hokkaido Prefecture, Japan, Sapporo
Foregrowth Canada, Ontario, Toronto
Invested Development Boston, Massachusetts, United States
Kakao Mobility Kyonggi-do, Seongnam, South Korea
Kowloon Nights China, Hong Kong, Hong Kong Island
Nassau Capital New Jersey, Princeton, United States
Stylebread Hokkaido, Hokkaido Prefecture, Japan
Sunrise Securities New York, New York, United States
Techinvest Austria, Vienna
Teradyne Massachusetts, North Reading, United States
ViaNet Ventures -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Degron Therapeutics

$22M09 Jun 2022 Shanghai, Shanghai, China

Microclear

Health Care
Manufacturing
Medical Device
23 May 2022 Gusu District, Jiangsu, China

GenFleet Therapeutics

Biotechnology
Health Care
Pharmaceutical
$77M31 Dec 2021 Shanghai, China

Zhimeng Biopharma

Biopharma
Biotechnology
Therapeutics
$54M08 Nov 2021 Zhangdian District, Shandong, China

Leads Biolabs

Biotechnology
Health Care
Pharmaceutical
$100M08 Oct 2021 Nanjing, Jiangsu, China

Ionova Life Science

Biotechnology
Health Care
$100M22 Aug 2021 Futian District, Guangdong Province, China

Biopharma
Biotechnology
Health Care
Pharmaceutical
$105M13 May 2021 Shanghai, China

Biotechnology
Pharmaceutical
Therapeutics
$40M07 May 2021 San Diego, California, United States

SceneRay

Medical Device
21 Apr 2021 Gusu District, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Dyee Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: